TY  - JOUR
AU  - Bernal, T
AU  - Martinez-Camblor, P
AU  - Sanchez-Garcia, J
AU  - Sanz, G
PY  - 2016
DO  - 10.1038/leu.2015.339
UR  - http://hdl.handle.net/10668/9724
T2  - Leukemia
AB  - There is an increasing interest on the effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes (MDS) outside clinical trials. We recently reported the lack of effect of this drug in an unselected population of 821...
LA  - en
PB  - Nature Publishing Group
KW  - Azacitidine
KW  - Retrospective studies
KW  - Myelodysplastic syndromes
KW  - Leukemia, myeloid, acute
KW  - Registries
KW  - Antimetabolites, antineoplastic
KW  - Azacitidine
KW  - Female
KW  - Humans
KW  - Male
KW  - Myelodysplastic syndromes
TI  - Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply.
TY  - research article
VL  - 30
ER  -